Who Paid My Doc
Vanta Adaptivestim
Device Spinal Cord Neurostimulation
PDI 00763000411923
General payments
$1,718,362
Research payments
$991,947
Through program year 2025, $1,718,362 in general payments and $991,947 in research payments were reported against Vanta Adaptivestim (Spinal Cord Neurostimulation).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
7 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $33,165 | 1,089 |
| 2025 | Research | $97,091 | 41 |
| 2024 | General | $198,244 | 1,986 |
| 2024 | Research | $303,110 | 66 |
| 2023 | General | $684,546 | 6,186 |
| 2023 | Research | $591,746 | 67 |
| 2022 | General | $802,407 | 6,517 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 36 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 32 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
15,778 general · 174 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.